Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? - 26/08/11
, Marcus Leibig, MD a, Thomas M. Schiele, MD a, Reiner Schrepf, MD a, Victoria Seelig, MD a, Hans-Ulrich Stempfle, MD, PD a, Petra Erdin, MD a, Johannes Rieber, MD a, Andreas König, MD a, Uwe Siebert, MD, MPH, MSc a, c, Volker Klauss, MD, PD aAbstract |
Background |
Achievement of maximal hyperemia of the coronary microcirculation is a prerequisite for the measurement of fractional flow reserve (FFR). Intravenous adenosine is considered the standard method, but its use in the catheterization laboratory is time consuming and expensive compared with intracoronary adenosine. Therefore, this study compared different high, intracoronary doses of adenosine for the potential to achieve a maximal hyperemia equivalent to the standard intravenous route.
Methods |
FFR was assessed in 50 patients with 50 intermediate lesions during cardiac catheterization. FFR was calculated as the ratio of the distal coronary pressure to the aortic pressure at hyperemia. Different incremental doses of intracoronary adenosine (60, 90, 120, and 150 μg as boli) and a standard intravenous infusion of 140 μg/kg/min were administered in a randomized fashion.
Results |
Different incremental doses of intracoronary adenosine were well tolerated, with fewer systemic adverse effects than intravenous adenosine. At baseline, there were no significant differences for mean aortic and distal coronary pressure or heart rate in the different adenosine doses and routes. FFR decreased with increasing adenosine doses, with the lowest values observed with the 150-μg intracoronary bolus and 140-μg/kg/min dose of intravenous adenosine. All intracoronary doses, except the 150-μg bolus, resulted in mean FFR values that were significantly (P <.05) higher than FFR after the administration intravenous adenosine. Furthermore, 5 patients (10%) with a FFR value >0.75 and 3 subjects (6%) with a FFR value >0.80 who received a 60-μg intracoronary bolus reached a value below the cutoff point of 0.75 with the intravenous administration.
Conclusions |
This study suggests a dose-response relationship on hyperemia for intracoronary adenosine doses >60 μg. The administration of very high intracoronary adenosine boli is safe and associated with fewer systemic adverse effects than standard intravenous adenosine. However, intravenous adenosine administration with 140 μg/kg/min produced a more pronounced hyperemia than intracoronary adenosine in most patients and should be the preferred mode of application for the assessment of FFR.
Le texte complet de cet article est disponible en PDF.Plan
Vol 148 - N° 4
P. 590-595 - octobre 2004 Retour au numéro
Article précédent
- Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction
- Milica Dekleva, Aleksandar Neskovic, Alja Vlahovic, Biljana Putnikovic, Branko Beleslin, Miodrag Ostojic
- Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM)
- Kristina Dunder, Lars Lind, Björn Zethelius, Lars Berglund, Hans Lithell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?